VAST THERAPEUTICS
Vast Therapeutics develops inhalable treatments for antibiotic-resistant pathogens present in cystic fibrosis and other respiratory disease patients. The company is in the preclinical stage of developing inhalable therapeutics to treat chronic infections common to the cystic fibrosis population.
VAST THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.vasttherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
919-321-1375
Email Addresses:
[email protected]
Total Funding:
15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Euro ReCAPTCHA AJAX Libraries API Google Analytics Classic Typekit Snowplow
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
John C. Oakley
John C. Oakley CFO @ Vast Therapeutics CFO
F. Neal Hunter
F. Neal Hunter CEO @ Vast Therapeutics CEO
Mark Schoenfisch
Mark Schoenfisch President and Chief Scientific Officer @ Vast Therapeutics President and Chief Scientific Officer
Charles M. Swoboda
Charles M. Swoboda President & Chief Executive Officer @ Vast Therapeutics President & Chief Executive Officer 2021-01-01
Investors List
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Series A - Vast Therapeutics
Shionogi
Shionogi investment in Series A - Vast Therapeutics
Official Site Inspections
http://www.vasttherapeutics.com Semrush global rank: 4.72 M Semrush visits lastest month: 853
Unable to get host informations!!!
Loading ...